12 Oct 2021 by admin in UncategorizedComments Syros Pharmaceuticals Announces Appointment of Jason Haas as Chief Financial Officer
12 Oct 2021 by admin in UncategorizedComments Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
07 Oct 2021 by admin in UncategorizedComments NextCure Announces Publication of Preclinical Data for NC410
05 Oct 2021 by admin in UncategorizedComments Pennovation Lab welcomes new tenant Interius BioTherapeutics to its innovation ecosystem
04 Oct 2021 by admin in UncategorizedComments NextCure Announces New Appointments to its Board of Directors
29 Sep 2021 by admin in UncategorizedComments Syros Announces First Patient in Dose Confirmation Study of SY-2101, a Novel Oral Form of Arsenic Trioxide, in Acute Promyelocytic Leukemia
28 Sep 2021 by admin in UncategorizedComments Syros Reports Inducement Grant to Chief Commercial Officer under Nasdaq Listing Rule 5635(c)(4)
27 Sep 2021 by admin in UncategorizedComments Syros Announces Appointment of Conley Chee as Chief Commercial Officer
20 Sep 2021 by admin in UncategorizedComments Tempest Announces First Patient Dosed in Randomized Study Evaluating TPST-1120 in First-Line Regimen for Hepatocellular Carcinoma in Clinical Collaboration with Roche
